返回 Agenda
Session Chair(s)
Steffen Thirstrup, MD, PHD
Chief Medical Officer
European Medicines Agency, Netherlands
Speaker(s)
Global Market Development of Biosimilars and Non-Originator Biologics in Emerging Markets
Per Troein, MBA, MSC
IQVIA, United Kingdom
VP Strategic Partners
Outcome of the October EC workshop on Access to and Uptake of Biosimilars
Hilda Juhász
European Commission, Belgium
Policy Officer
European Generics and Biosimilar Medicines Association's view on market developments
Pieter Dylst, DrPH, MPHARM, RPH
Medicines For Europe, Belgium
Senior Manager Market Access & Value Added Medicines
European Biopharmaceutical Enterprises and EFPIA's view on market developments
Alexander Roediger, MA, MBA
MSD Sharp and Dohme GmbH, Switzerland
Executive Director EMEAC Oncology Policy